GlobalData
GlobalData

Beth

Ardelyx’s tenapanor has potential to capture a slice of the CKD-HP market, says GlobalData

Ardelyx’s tenapanor has the potential to capture a slice of the chronic kidney disease (CKD)-hyperphosphatemia (HP) market if the company can successfully appeal the Food and Drug Administration’s Appeal Denied Letter (ADL), says GlobalData. The leading data and analytics company notes that tenapanor’s potential is based on its ability to target dialysis-dependent patients who are […]
Read more

Novartis’ Leqvio has potential to lead the cholesterol-lowering space due to its administration convenience, says GlobalData

Sales for Novartis’ Leqvio (inclisiran) for the treatment of high cholesterol may surpass those of Sanofi/Regeneron’s Repatha (evolocumab) and Amgen’s Praluent (alirocumab) by 2027 due to its administration convenience, according to GlobalData. The leading data and analytics company notes that Leqvio is in a better position compared to its competitors as it is administered by […]
Read more

TJX job listings triple in 2021 with a focus on retail store operations, finds GlobalData

In a world of bargain hunters, TJX Companies—the owner of brands such as TJ Maxx, Marshalls and HomeGoods that offer high-quality goods at lower prices—has listed 69,000 roles in 2021, representing a three-fold jump over 2020, according to GlobalData’s Job Analytics Database. The leading data and analytics company notes that TJX’s increased listings are mainly […]
Read more

Low-value deals dominate deal volume in 2021 but VC firms’ appetite for big-tickets deals grows significantly, finds GlobalData

While low-value deals* accounted for the majority of global venture capital (VC) investment volume in 2021, the volume of big-ticket VC deals** increased by an impressive 178.2%, from 477 deals in 2020 to 1,327 deals in 2021, according to GlobalData, a leading data and analytics company. A total of 24,487 VC deals with disclosed funding […]
Read more

Tower Semiconductor is a useful addition for Intel, but investors await its take on the metaverse, says GlobalData

Following the news that Intel will acquire Tower Semiconductor: David Bicknell, Principal Analyst in the Thematic Research Team at GlobalData, a leading data and analytics company, offers his view: “Intel’s proposed acquisition of Tower Semiconductor will bolster its production of trailing edge chips, something that is vital for many companies, particularly automakers. Tower Semiconductor will […]
Read more

Jobs Recap: Job postings increase globally; hiring for recruiters increased by 30% month-on-month, finds GlobalData

Companies appear to be gearing up for a hiring spree, according to GlobalData, which notes that the number of companies seeking a ‘Recruiter’ has increased by 30% between December 2021 and January 2022. The leading data and analytics company reveals that there was over 6,000 ‘recruiter’ job postings in January. Listings for ‘Recruiters’ were the […]
Read more

Indonesian defense acquisitions a significant win for France after tough year following AUKUS, says GlobalData

Following the news that the Indonesian Armed Forces are to procure 42 Rafale fighter jets from Dassault aviation, and have signed a memorandum of understanding (MoU) for submarine research and development (R&D) work and ammunition manufacturing; Madeline Wild, Associate Defense Analyst at GlobalData, a leading data and analytics company, comments: “The Franco-Indonesian deals are a […]
Read more

Nearly 12,000 companies discussed the likelihood of insolvency in 2021, says GlobalData

As companies struggled financially during 2021, firms discussed the possibility of being unable to operate as a *‘going concern’. An analysis of GlobalData’s Company Filing Analytics database found that the number of companies that discussed ‘going concern’ and ‘doubt’ remains high at nearly 12,000, despite witnessing a slight decline of 9% in 2021 over 2020. […]
Read more

AI together with Big Data will be the most disruptive emerging technology duo in the pharmaceutical sector in 2022, says GlobalData

Despite being years away from exhibiting its full potential, artificial intelligence (AI), together with Big Data, stand out as a versatile combination to address challenges faced by the entire pharmaceutical value chain, says GlobalData, a leading data and analytics company. In GlobalData’s latest report, ‘The State of the Biopharmaceutical Industry – 2022’, AI, followed by […]
Read more
1 23 24 25 26 27 93